---
title: "BrainAurora Chair Plans Up to HKD80 Million Share Purchase to Boost Stake"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/282689289.md"
description: "BrainAurora Medical Technology Limited (HK:6681) announced that its chairman, Tan Zheng, plans to purchase up to HKD80 million worth of shares to increase his stake in the company over the next six months. The purchases will be made at a maximum price of HKD7 per share, reflecting confidence in the company's long-term value. Currently, Tan holds about 33.83% of the company's shares. However, the company cautioned that the plan may be affected by market conditions and advised shareholders to be aware of investment risks."
datetime: "2026-04-14T12:09:35.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/282689289.md)
  - [en](https://longbridge.com/en/news/282689289.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/282689289.md)
---

# BrainAurora Chair Plans Up to HKD80 Million Share Purchase to Boost Stake

### Claim 30% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

BrainAurora Medical Technology Limited ( (HK:6681) ) has issued an announcement.

BrainAurora Medical Technology Limited announced that its controlling shareholder, executive director and chairman, Tan Zheng, plans to increase his stake in the company by purchasing shares on the open market over the next six months. Using his own funds, Tan intends to invest up to HKD80 million at a maximum price of HKD7 per share, while ensuring compliance with Hong Kong listing rules and maintaining sufficient public float.

Tan and his concert parties currently hold about 33.83% of BrainAurora’s issued share capital, and the board views the planned purchases as a signal of strong confidence in the group’s long-term development and value. The company also cautioned investors that the plan may not be fully executed due to market conditions and other unforeseen factors, and reminded shareholders to remain mindful of investment risks when trading its shares.

**More about BrainAurora Medical Technology Limited**

BrainAurora Medical Technology Limited is a Cayman Islands–incorporated company listed in Hong Kong that operates in the medical technology sector. The group focuses on developing and commercialising medical technologies, with its shares traded on the Main Board of the Stock Exchange of Hong Kong under stock code 6681.

**Average Trading Volume:** 23,442,096

**Technical Sentiment Signal:** Strong Sell

**Current Market Cap:** HK$5.54B

### Related Stocks

- [06681.HK](https://longbridge.com/en/quote/06681.HK.md)

## Related News & Research

- [BrainAurora Controlling Shareholder Extends Lock-Up on 20% Stake to 2027](https://longbridge.com/en/news/275044544.md)
- [Venus Medtech Executive Director Resigns, Board Signals Smooth Transition](https://longbridge.com/en/news/286563434.md)
- [06:56 ETWest Coast Informatics Appoints Regis Charlot to Board of Directors](https://longbridge.com/en/news/286402934.md)
- [Shyld AI Raises $13.4M to Expand Active AI Across U.S. Hospitals](https://longbridge.com/en/news/286444119.md)
- [Craneware Completes $25m Share Buyback, Sets New Voting Rights](https://longbridge.com/en/news/286206627.md)